glp 1 drugs covered by medicaid MCT2D Medicaid covers GLP-1 meds for

The cultural relevance of drinking means that GLP-1 users who drink less might feel left out

1 T2DM remains as one of the leading causes of disability and death worldwide mainly due to its long-term vascular complications

Key Findings 93.4% of patients would get bariatric surgery again 51.4% of patients would consider using GLP-1 drugs again 57.1% of GLP-1 patients reported losing at least 20 pounds 98.1% of bariatric surgery patients reported losing at least 20 pounds Median weight loss for bariatric surgery patients was 100 pounds, as opposed to 20 for GLP-1s Average weight loss for bariatric surgery was reported to be 101.2, as opposed to 24.9 for GLP-1 users 93.4% of Patients Would Get Bariatric Surgery Again Out of all patients surveyed, 93.4% said they would get bariatric surgery again

Data correspond to usage on the plateform after 2015

Forest plot of GLP-1 receptor agonists versus comparators on the risk of Pulmonary edema

However, larger and longer-term studies are still needed to comprehensively evaluate its impact on key liver issues and fully assess its safety profile